United States Nadroparin Market Report 2016

October 2016 | 121 pages | ID: U443026E954EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nadroparin

Revenue, means the sales value of Nadroparin

This report studies sales (consumption) of Nadroparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Nadroparin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Nadroparin Market Report 2016

1 NADROPARIN OVERVIEW

1.1 Product Overview and Scope of Nadroparin
1.2 Classification of Nadroparin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Nadroparin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nadroparin (2011-2021)
  1.4.1 United States Nadroparin Sales and Growth Rate (2011-2021)
  1.4.2 United States Nadroparin Revenue and Growth Rate (2011-2021)

2 UNITED STATES NADROPARIN COMPETITION BY MANUFACTURERS

2.1 United States Nadroparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nadroparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nadroparin Average Price by Manufactures (2015 and 2016)
2.4 Nadroparin Market Competitive Situation and Trends
  2.4.1 Nadroparin Market Concentration Rate
  2.4.2 Nadroparin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NADROPARIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Nadroparin Sales and Market Share by Type (2011-2016)
3.2 United States Nadroparin Revenue and Market Share by Type (2011-2016)
3.3 United States Nadroparin Price by Type (2011-2016)
3.4 United States Nadroparin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NADROPARIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Nadroparin Sales and Market Share by Application (2011-2016)
4.2 United States Nadroparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NADROPARIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Nadroparin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Nadroparin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Nadroparin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Nadroparin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Nadroparin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Nadroparin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Nadroparin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Nadroparin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Nadroparin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Nadroparin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 NADROPARIN MANUFACTURING COST ANALYSIS

6.1 Nadroparin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nadroparin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Nadroparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nadroparin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NADROPARIN MARKET FORECAST (2016-2021)

10.1 United States Nadroparin Sales, Revenue Forecast (2016-2021)
10.2 United States Nadroparin Sales Forecast by Type (2016-2021)
10.3 United States Nadroparin Sales Forecast by Application (2016-2021)
10.4 Nadroparin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nadroparin
Table Classification of Nadroparin
Figure United States Sales Market Share of Nadroparin by Type in 2015
Table Application of Nadroparin
Figure United States Sales Market Share of Nadroparin by Application in 2015
Figure United States Nadroparin Sales and Growth Rate (2011-2021)
Figure United States Nadroparin Revenue and Growth Rate (2011-2021)
Table United States Nadroparin Sales of Key Manufacturers (2015 and 2016)
Table United States Nadroparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nadroparin Sales Share by Manufacturers
Figure 2016 Nadroparin Sales Share by Manufacturers
Table United States Nadroparin Revenue by Manufacturers (2015 and 2016)
Table United States Nadroparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nadroparin Revenue Share by Manufacturers
Table 2016 United States Nadroparin Revenue Share by Manufacturers
Table United States Market Nadroparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nadroparin Average Price of Key Manufacturers in 2015
Figure Nadroparin Market Share of Top 3 Manufacturers
Figure Nadroparin Market Share of Top 5 Manufacturers
Table United States Nadroparin Sales by Type (2011-2016)
Table United States Nadroparin Sales Share by Type (2011-2016)
Figure United States Nadroparin Sales Market Share by Type in 2015
Table United States Nadroparin Revenue and Market Share by Type (2011-2016)
Table United States Nadroparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nadroparin by Type (2011-2016)
Table United States Nadroparin Price by Type (2011-2016)
Figure United States Nadroparin Sales Growth Rate by Type (2011-2016)
Table United States Nadroparin Sales by Application (2011-2016)
Table United States Nadroparin Sales Market Share by Application (2011-2016)
Figure United States Nadroparin Sales Market Share by Application in 2015
Table United States Nadroparin Sales Growth Rate by Application (2011-2016)
Figure United States Nadroparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Nadroparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Nadroparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Nadroparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Nadroparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Nadroparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Nadroparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Nadroparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Nadroparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Nadroparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Nadroparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Nadroparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Nadroparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nadroparin
Figure Manufacturing Process Analysis of Nadroparin
Figure Nadroparin Industrial Chain Analysis
Table Raw Materials Sources of Nadroparin Major Manufacturers in 2015
Table Major Buyers of Nadroparin
Table Distributors/Traders List
Figure United States Nadroparin Production and Growth Rate Forecast (2016-2021)
Figure United States Nadroparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Nadroparin Production Forecast by Type (2016-2021)
Table United States Nadroparin Consumption Forecast by Application (2016-2021)